RNA Analysis/Transcriptomics Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

RNA Analysis/Transcriptomics Market
RNA Analysis/Transcriptomics Market: By Type (Microarrays, Polymerase Chain Reaction), By Application (Clinical Diagnosis, Drug Discovery, Toxicogenomics), By End User (Academic Research & Government Institutes, Hospitals & Diagnosis Centres) & By Region - Forecast (2018- 2023)
Report Code : HCR 0433
Updated Date: 02 May, 2018  

1. RNA Analysis/Transcriptomics Market – Overview
2. Executive Summary 
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. RNA Analysis/Transcriptomics Market– Forces
   4.1. Drivers
      4.1.1. Increasing applications of RNA Sequencing and transpcriptomatic research
      4.1.2. Increasing R&D activities amongst bio tech companies
   4.2. Restraints
      4.2.1. High capital requirement and limitations of transcriptomatic technologies
   4.3. Opportunities
      4.3.1. Developing nations presents high growth opportunity
      4.3.2. Toxicogenomics As An Application to Open New Growth Avenues
   4.4. Challenges
      4.4.1. Lack of Effective Bioinformatics tools for Transcriptomic Analysis
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. RNA Analysis/Transcriptomics Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life cycle Analysis
   5.5. Suppliers & Distributors
6. RNA Analysis/Transcriptomics Market, By Type
   6.1. Microarrays
   6.2. Polymerase Chain Reaction (PCR) 
   6.3. Sequencing Technologies  
   6.4. RNAI Gene Silencing 
7. RNA Analysis/Transcriptomics Market, By Applications
   7.1. Clinical Diagnosis 
   7.2. Drug Discovery 
   7.3. Toxicogenomics
8. RNA Analysis/Transcriptomics Market, By End User
   8.1. Academic Research & Government Institutes 
   8.2. Pharmaceutical & Biotechnology Companies 
   8.3. Hospitals & Diagnostic Centers
9. RNA Analysis/Transcriptomics Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America 
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Middle East
      9.4.2. South America
      9.4.3. Africa
10. RNA Analysis/Transcriptomics – Market Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. Affymetrix Inc. 
   11.2. Agilent Technologies, Inc.
   11.3. Bio-Rad Laboratories, Inc. 
   11.4. GE Healthcare 
   11.5. Illumina, Inc. 
   11.6. Qiagen N.V.
   11.7. F. Hoffmann-La Roche Ltd. 
   11.8. Sigma-Aldrich Corporation 
   11.9. Thermo Fisher Scientific, Inc. 
   11.10. Fluidigm Corporation  
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibiliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $7250
Related Reports
0px;">Scroll